Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer’s Disease by Targeting Aβ Oligomers

Bing Liu, Xiaofang Li, Zhengyang Liu, Bing He, Hanyue Xu, Jianqin Cao, Fantian Zeng, Haiwei Feng, Yanwei Ren, Haoyu Li, Tianyu Wang, Jia Li, Yuting Ye, Li Zhao, Chongzhao Ran, Yuyan LiJournal of Medicinal Chemistry 2024 · DOI

Abstract

Amyloid-β oligomers (AβOs), crucial toxic proteins in early Alzheimer's disease (AD), precede the formation of Aβ plaques and cognitive impairment. In this context, we present our iterative process for developing novel near-infrared fluorescent (NIRF) probes specifically targeting AβOs, aimed at early AD diagnosis. An initial screening identified compound <b>18</b> as being highly selective for AβOs. Subsequent analysis revealed that compound <b>20</b> improved serum stability while retaining affinity for AβOs. The most promising iteration, compound <b>37</b>, demonstrated exceptional qualities: a high affinity for AβOs, emission in the near-infrared region, and good biocompatibility. Significantly, <i>ex vivo</i> double staining indicated that compound <b>37</b> detected AβOs in AD mouse brain and <i>in vivo</i> imaging experiments showed that compound <b>37</b> could differentiate between 4-month-old AD mice and age-matched wild-type mice. Therefore, compound <b>37</b> has emerged as a valuable NIRF probe for early detection of AD and a useful tool in exploring AD's pathological mechanisms.
BibTeX
@article{liu2024iterative,
  author = {Bing Liu and Xiaofang Li and Zhengyang Liu and Bing He and Hanyue Xu and Jianqin Cao and Fantian Zeng and Haiwei Feng and Yanwei Ren and Haoyu Li and Tianyu Wang and Jia Li and Yuting Ye and Li Zhao and Chongzhao Ran and Yuyan Li},
  title = {{Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer’s Disease by Targeting Aβ Oligomers}},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00252},
}

Loading related content...

Figure